Safety, Immunogenicity, and Efficacy of Recombinant COVID-19 Inhalation Vaccine (adenovirus Type 5 Vector) As Second Booster Dose Against Emerging Variants of Concern (VOC) of SARS-CoV-2 to Prevent Breakthrough Infections: an Observer-Blinded, Randomised, Phase 3, Non-Inferiority Trial
crossref(2024)
摘要
Download This Paper Open PDF in Browser Add Paper to My Library Share: Permalink Using these links will ensure access to this page indefinitely Copy URL Copy DOI
更多查看译文
关键词
Vaccines
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要